JPH05331157A - Ascorbic acid ester - Google Patents

Ascorbic acid ester

Info

Publication number
JPH05331157A
JPH05331157A JP4133572A JP13357292A JPH05331157A JP H05331157 A JPH05331157 A JP H05331157A JP 4133572 A JP4133572 A JP 4133572A JP 13357292 A JP13357292 A JP 13357292A JP H05331157 A JPH05331157 A JP H05331157A
Authority
JP
Japan
Prior art keywords
ascorbic acid
compound
lipase
formula
acid ester
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP4133572A
Other languages
Japanese (ja)
Inventor
Keiichi Sakashita
啓一 坂下
Shiro Miyamoto
志朗 宮本
Toshitaka Uragaki
俊孝 浦垣
Akihiro Sakimae
明宏 崎前
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mitsubishi Rayon Co Ltd
Original Assignee
Mitsubishi Rayon Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mitsubishi Rayon Co Ltd filed Critical Mitsubishi Rayon Co Ltd
Priority to JP4133572A priority Critical patent/JPH05331157A/en
Publication of JPH05331157A publication Critical patent/JPH05331157A/en
Pending legal-status Critical Current

Links

Abstract

PURPOSE:To provide a new compound having reducing power and polymerizability and giving a useful hydrophilic polymer or a polymer having reducing power by homopolymerization or copolymerization with other polymerizable compound. CONSTITUTION:The compound of formula I (R1 is H or methyl), e.g. ascorbic acid methacrylate. The compound of formula I can be produced by reacting a (meth)acrylic acid enol ester of formula II with ascorbic acid in an organic solvent (e.g. t-butanol) in the presence of lipase at 30-60 deg.C for 10-50hr. A lipase having ester interchange activity, e.g. genus Pseudomonas (Lipase PS, product of Amano Pharmaceuticals Co.) can be used in the present process. The amount of the compound of formula II is preferably 5-20% in excess of ascorbic acid.

Description

【発明の詳細な説明】Detailed Description of the Invention

【0001】[0001]

【産業上の利用分野】本発明は新規なアスコルビン酸エ
ステルに関する。
FIELD OF THE INVENTION The present invention relates to a novel ascorbic acid ester.

【0002】[0002]

【従来の技術】アスコルビン酸と脂肪族カルボン酸のエ
ステル例えばアスコルビン酸パルミテートは特開昭54
−88261号公報などに記載されているがアスコルビ
ン酸(メタ)アクリル酸エステルに関しては従来知られ
ていない。
2. Description of the Related Art Esters of ascorbic acid and aliphatic carboxylic acids such as ascorbic acid palmitate are disclosed in JP-A-54.
However, ascorbic acid (meth) acrylic acid ester has not been known so far.

【0003】[0003]

【発明が解決しようとする課題】還元能と重合性を有す
る新規なアスコルビン酸(メタ)アクリル酸エステルを
提供する。
PROBLEM TO BE SOLVED BY THE INVENTION A novel ascorbic acid (meth) acrylic acid ester having reducing ability and polymerizability is provided.

【0004】[0004]

【課題を解決するための手段】本発明は下記の一般式
(1)で表わされるアスコルビン酸エステルである。
The present invention is an ascorbic acid ester represented by the following general formula (1).

【0005】[0005]

【化2】 [Chemical 2]

【0006】(式中R1 は水素又はメチル基を示す。)
本発明の上記一般式(1)で表わされるアスコルビン酸
エステルは、還元能を有すると共に、重合性官能基を有
するので、単独で、あるいは他の重合性化合物と共重合
させ、親水性高分子あるいは還元能のある高分子として
有用である。以下、上記一般式(1)で表わされる本発
明のアスコルビン酸エステルの製造方法につき説明す
る。本発明化合物は例えば下記に示す各種の方法により
製造される。
(In the formula, R 1 represents hydrogen or a methyl group.)
Since the ascorbic acid ester represented by the above general formula (1) of the present invention has a reducing ability and a polymerizable functional group, it may be used alone or in copolymerization with another polymerizable compound to obtain a hydrophilic polymer or It is useful as a polymer with reducing ability. Hereinafter, the method for producing the ascorbic acid ester of the present invention represented by the above general formula (1) will be described. The compound of the present invention is produced, for example, by various methods shown below.

【0007】(製造法A) 一般式(2)(Production Method A) General Formula (2)

【0008】[0008]

【化3】 [Chemical 3]

【0009】〔式中、R1 、R2 は各々独立に水素又は
メチル基を示す。〕で表わされる(メタ)アクリル酸エ
ノールエステルと、アスコルビン酸を有機溶媒中リパー
ゼの存在下に反応させる。この方法は酵素の選択的な反
応性を利用するもので温和な条件下で反応できるので有
利である。反応溶媒としては、ピリジン、t−ブタノー
ル、テトラヒドロフラン、ジオキサン、t−アミルアル
コールなどがあげられるが、この他にもアスコルビン酸
の溶解度が大きいものであれば使用できる。リパーゼは
エステル交換反応の能力のあるものであれば、いずれで
も使用できるが、シュードモナス属(天野製薬、リパー
ゼPS)、ムコール属(天野製薬、リパーゼM10)、
アスペルギラス属(天野製薬、リパーゼアマノA6)、
リゾポス属(大阪細菌研究所,リパーゼダイケン10
0)、キャンディダ属(シグマ、リパーゼタイプVII )
などの微生物由来のものや、パンクレアチンなどの動物
由来のものなどを例示できる。
[In the formula, R 1 and R 2 each independently represent hydrogen or a methyl group. ] The (meth) acrylic acid enol ester represented by the following formula is reacted with ascorbic acid in the presence of lipase in an organic solvent. This method utilizes the selective reactivity of the enzyme and is advantageous because it can react under mild conditions. Examples of the reaction solvent include pyridine, t-butanol, tetrahydrofuran, dioxane, t-amyl alcohol, and the like. In addition to these, any solvent having a high solubility of ascorbic acid can be used. Any lipase can be used as long as it has the ability of transesterification, but Pseudomonas sp. (Amano Pharmaceutical Co., Lipase PS), Mucor sp. (Amano Pharmaceutical Co., Lipase M10),
Aspergillus (Amano Pharmaceutical Co., Lipase Amano A6),
Rhizopos (Osaka Bacterial Research Institute, Lipase Daiken 10
0), Candida (sigma, lipase type VII)
Examples thereof include those derived from microorganisms such as, and those derived from animals such as pancreatin.

【0010】リパーゼのエステル交換能を発揮させるた
めには酵素の三次元構造を発現もしくは維持するために
微量の水が必要であるため、市販リパーゼの使用に際し
てはバッファー液で処理するなどして活性を賦括してか
ら処理することが好ましい。またリパーゼ又はリパーゼ
源を不溶性担体に固定化して利用することも可能であ
る。リパーゼを使用する場合の反応温度は30℃から6
0℃であり、反応時間は10〜50時間が好ましい。
In order to exert the transesterification ability of lipase, a trace amount of water is required to express or maintain the three-dimensional structure of the enzyme. Therefore, when using commercially available lipase, it is necessary to treat it with a buffer solution to activate it. It is preferable that the treatment is carried out after the treatment. It is also possible to immobilize a lipase or a lipase source on an insoluble carrier before use. The reaction temperature when using lipase is from 30 ° C to 6 ° C.
It is 0 ° C., and the reaction time is preferably 10 to 50 hours.

【0011】化合物(2)はアスコルビン酸に対して当
量用いる事ができるが、反応の効率を考えると、5%〜
20%過剰に用いるのが良い。反応終了後酵素を分離
し、反応液を濃縮し、得られた粗製物を再結晶する事に
より精製する。以上の合成の詳細は実施例において記述
する。
The compound (2) can be used in an equivalent amount with respect to ascorbic acid.
It is better to use an excess of 20%. After completion of the reaction, the enzyme is separated, the reaction solution is concentrated, and the obtained crude product is recrystallized for purification. Details of the above synthesis will be described in Examples.

【0012】(製造法B) 一般式(3)(Production Method B) General Formula (3)

【0013】[0013]

【化4】 [Chemical 4]

【0014】〔式中、R1 は前記に同じ〕とアスコルビ
ン酸とを反応させる。上記反応は溶媒中、−10〜20
℃、好ましくは0〜10℃、反応時間5〜40時間で行
なわれる。化合物(3)は、アスコルビン酸に対して過
剰量用いるのが、反応効率から好ましいが、化合物
(3)は反応性が大きいので、二級水酸基への反応も若
干進行し、反応選択率が低下する可能性がある。従っ
て、化合物(3)を当量もしくは1〜10%少なめに添
加する方が好ましい。反応中、塩化水素が発生するが、
これをトラップする目的で塩基性化合物、例えばアルカ
リ、アミンなどを加えることができる。しかし、アスコ
ルビン酸がこれらの添加により酸化されやすくなるの
で、添加しなくともよい。溶媒としては水、テトラヒド
ロフラン、ジオキサン、ジメチルホルムアミド、ジメチ
ルスルホキシド、アセトン、クロロホルムなど及びこれ
らの溶媒の混合溶媒を使用できる。
[Wherein R 1 is the same as above] is reacted with ascorbic acid. The above reaction is carried out in a solvent at -10 to 20.
C., preferably 0-10.degree. C., and a reaction time of 5-40 hours. It is preferable to use an excessive amount of the compound (3) with respect to ascorbic acid from the viewpoint of reaction efficiency. However, since the compound (3) has a high reactivity, the reaction to the secondary hydroxyl group also slightly progresses and the reaction selectivity decreases. there's a possibility that. Therefore, it is preferable to add the compound (3) in an equivalent amount or 1 to 10% less. Hydrogen chloride is generated during the reaction,
A basic compound such as an alkali or an amine can be added for the purpose of trapping this. However, since ascorbic acid is easily oxidized by the addition of these, it is not necessary to add it. As the solvent, water, tetrahydrofuran, dioxane, dimethylformamide, dimethylsulfoxide, acetone, chloroform and the like and mixed solvents of these solvents can be used.

【0015】(製造法C) 一般式(4)(Production Method C) General Formula (4)

【0016】[0016]

【化5】 [Chemical 5]

【0017】(式中、R1 は前記と同じ)製造法Bの化
合物(3)の代りに化合物(4)を用いる他は製造法B
と全く同様に行なうことができる。ただし、反応の進行
を早めるため塩基性縮合剤例えばピリジン、ピコリン、
N,N−ジメチルアミノピリジン、トリエチルアミンな
どの添加が好ましい。上記製造法B,Cによって得られ
る本発明化合物は反応終了後通常の分離方法に従って単
離できる。
(Wherein R 1 is the same as above) except that the compound (4) is used instead of the compound (3) of the manufacturing method B.
You can do exactly the same as. However, in order to accelerate the reaction, basic condensing agents such as pyridine, picoline,
Addition of N, N-dimethylaminopyridine, triethylamine and the like is preferable. The compound of the present invention obtained by the above production methods B and C can be isolated by a usual separation method after the reaction is completed.

【0018】[0018]

【実施例】次に本発明を更に説明するため、本発明の化
合物の製造例を実施例としてあげる。
EXAMPLES Next, in order to further explain the present invention, production examples of the compounds of the present invention will be given as Examples.

【0019】実施例1 アスコルビン酸メタアクリル酸エステルの合成 リパーゼPS(天野製薬)1gをpH7.0、1/20
Mリン酸バッファー25mlに溶解し、大豆レシチン
0.8gを加え攪拌する。これにケイソウ土10gを加
えてさらに攪拌したのち40℃で減圧濃縮した。これを
さらに40℃で減圧乾燥して固定化リパーゼPS11.
8gを調製した。この固定化リパーゼPSから4gをと
り、あらかじめ40℃でアスコルビン酸4gを脱水t−
ブタノール40mlに溶解した溶液に添加し、さらにメ
タクリル酸ビニルエステル2.7g(1.05当量)を
加え40℃で24時間反応させる。反応液をHPLCで
分析すると反応率は95%であった。固定化リパーゼP
Sを濾別し、反応液を濃縮した。得られた粗生成物をア
セトン/ベンゼン混合溶媒にて再結晶をくり返すと、
2.3gのアスコルビン酸メタクリル酸エステルが得ら
れた。
Example 1 Synthesis of ascorbic acid methacrylic acid ester 1 g of lipase PS (Amano Pharmaceutical Co., Ltd.) was added at pH 7.0 and 1/20.
Dissolve in 25 ml of M phosphate buffer, add 0.8 g of soybean lecithin, and stir. To this, 10 g of diatomaceous earth was added, further stirred, and then concentrated under reduced pressure at 40 ° C. This was further dried under reduced pressure at 40 ° C. and immobilized lipase PS11.
8 g was prepared. 4 g of this immobilized lipase PS was taken and 40 g of ascorbic acid was dehydrated at 40 ° C. in advance.
It is added to a solution dissolved in 40 ml of butanol, 2.7 g (1.05 equivalent) of vinyl methacrylate is further added, and the mixture is reacted at 40 ° C. for 24 hours. When the reaction solution was analyzed by HPLC, the reaction rate was 95%. Immobilized lipase P
S was filtered off and the reaction solution was concentrated. When the obtained crude product was repeatedly recrystallized with an acetone / benzene mixed solvent,
2.3 g of ascorbic acid methacrylic acid ester was obtained.

【0020】mp.153−156℃,M+ =244.
0583(C10127 1 H−NMR(CD3 CN);δ 1.92(3H,
s),4.12(1H,m),4.24(2H,m),
4.77(1H,d,J=1.6Hz),5.65(1
H,d,J=1.6Hz),6.13(1H,d,J=
1.6Hz),13 C−NMR(CD3 CN);δ 16.54,63.
80,65.72,74.28,117.98,12
4.59,135.30,149.53,165.8
1,168.71
Mp. 153-156 ° C, M + = 244.
0583 (C 10 H 12 O 7 ) 1 H-NMR (CD 3 CN); δ 1.92 (3H,
s), 4.12 (1H, m), 4.24 (2H, m),
4.77 (1H, d, J = 1.6Hz), 5.65 (1
H, d, J = 1.6 Hz), 6.13 (1H, d, J =
1.6 Hz), 13 C-NMR (CD 3 CN); δ 16.54, 63.
80, 65.72, 74.28, 117.98, 12
4.59, 135.30, 149.53, 165.8
1,168.71

【0021】実施例2 アスコルビン酸アクリル酸エステルの合成 実施例1におけるメタクリル酸ビニルエステルの代りに
アクリル酸ビニルエステルを使用した以外は全く同様に
反応、精製を行なって1.8gのアスコルビン酸アクリ
ル酸エステルを得た。
Example 2 Synthesis of Ascorbic Acid Acrylic Acid Ester 1.8 g of ascorbic acid acrylic acid was prepared by the same reaction and purification as in Example 1 except that vinyl acrylate was used instead of vinyl methacrylate. The ester was obtained.

【0022】mp.153−162℃,M+ =230.
0417(C9 107 1 H−NMR(アセトン−d6 );δ 4.24(1
H,m),4.33(2H,m),4.84(1H,
d,J=1.6Hz),5.93(1H,dd,J=
1.6,10.8Hz),6.19(1H,dd,J=
10.8,17.2Hz),6.41(1H,dd,J
=1.6,17.6Hz)
Mp. 153-162 ° C, M + = 230.
0417 (C 9 H 10 O 7 ) 1 H-NMR (acetone-d 6 ); δ 4.24 (1
H, m), 4.33 (2H, m), 4.84 (1H,
d, J = 1.6 Hz), 5.93 (1H, dd, J =
1.6, 10.8 Hz), 6.19 (1H, dd, J =
10.8, 17.2Hz), 6.41 (1H, dd, J
= 1.6, 17.6 Hz)

【0023】実施例3 アスコルビン酸メタクリル酸エステルの合成 アスコルビン酸3.5gを脱水テトラヒドロフラン30
mlに溶解し、脱水トリエチルアミン1gを加え氷水で
冷却する。メタクリル酸クロリド1g(0.95当量)
を滴下し、滴下終了後室温で5時間攪拌の後、反応液を
40℃にて減圧乾固する。得られた粗製物にアセトン/
ベンゼン混合溶媒を加え加熱し、不溶物を熱時ろ過で除
く。ろ液を冷却して0.8gのアスコルビン酸メタアク
リル酸エステルが得られた。
Example 3 Synthesis of Ascorbic Acid Methacrylic Acid Ester 3.5 g of ascorbic acid was added to dehydrated tetrahydrofuran 30
Dissolve in ml, add 1 g of dehydrated triethylamine and cool with ice water. Methacrylic acid chloride 1g (0.95 equivalent)
Is added dropwise, and after completion of the addition, the mixture is stirred at room temperature for 5 hours, and then the reaction solution is dried under reduced pressure at 40 ° C. Acetone /
Add benzene mixed solvent and heat to remove insoluble matter by filtration while hot. The filtrate was cooled and 0.8 g of ascorbic acid methacrylic acid ester was obtained.

【0024】実施例4 アスコルビン酸アクリル酸エステルの合成 実施例3のメタクリル酸クロリドの代りにアクリル酸無
水物を使用した以外は全く同様に反応させ、反応液を処
理して0.6gのアスコルビン酸アクリル酸エステルを
得た。
Example 4 Synthesis of Ascorbic Acid Acrylate Ester The reaction was carried out in the same manner except that acrylic acid anhydride was used in place of the methacrylic acid chloride of Example 3, and the reaction solution was treated to give 0.6 g of ascorbic acid. Acrylic ester was obtained.

【0025】[0025]

【発明の効果】新規な重合性のアスコルビン酸エステル
が得られる。
The novel polymerizable ascorbic acid ester can be obtained.

───────────────────────────────────────────────────── フロントページの続き (51)Int.Cl.5 識別記号 庁内整理番号 FI 技術表示箇所 (C12P 17/04 C12R 1:66) (72)発明者 崎前 明宏 広島県大竹市御幸町20番1号 三菱レイヨ ン株式会社中央研究所内─────────────────────────────────────────────────── ─── Continuation of the front page (51) Int.Cl. 5 Identification number Reference number within the agency FI technical display location (C12P 17/04 C12R 1:66) (72) Inventor Akihiro Sakimae 20 Miyukicho, Otake City, Hiroshima Prefecture No. 1 Mitsubishi Rayon Co., Ltd. Central Research Laboratory

Claims (1)

【特許請求の範囲】[Claims] 【請求項1】 次式(1): 【化1】 (式中R1 は水素又はメチル基を示す。)で表わされる
アスコルビン酸エステル。
1. The following formula (1): (In the formula, R 1 represents hydrogen or a methyl group.) An ascorbic acid ester.
JP4133572A 1992-05-26 1992-05-26 Ascorbic acid ester Pending JPH05331157A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP4133572A JPH05331157A (en) 1992-05-26 1992-05-26 Ascorbic acid ester

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP4133572A JPH05331157A (en) 1992-05-26 1992-05-26 Ascorbic acid ester

Publications (1)

Publication Number Publication Date
JPH05331157A true JPH05331157A (en) 1993-12-14

Family

ID=15107948

Family Applications (1)

Application Number Title Priority Date Filing Date
JP4133572A Pending JPH05331157A (en) 1992-05-26 1992-05-26 Ascorbic acid ester

Country Status (1)

Country Link
JP (1) JPH05331157A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003073372A (en) * 2001-08-30 2003-03-12 Manac Inc Method for producing phenylethynyl phthalic anhydride derivative
WO2021049472A1 (en) * 2019-09-10 2021-03-18 学校法人 関西大学 Compound, resin, composition, resist film, pattern forming method, underlayer film, and optical article

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003073372A (en) * 2001-08-30 2003-03-12 Manac Inc Method for producing phenylethynyl phthalic anhydride derivative
WO2021049472A1 (en) * 2019-09-10 2021-03-18 学校法人 関西大学 Compound, resin, composition, resist film, pattern forming method, underlayer film, and optical article

Similar Documents

Publication Publication Date Title
JPH1081648A (en) Enantiomerangereicherte malonic acid monoester alphamonosubstituted with tertiary hydrocarbon group or its salt and its production
US5614643A (en) Process for the enzymatic production of isomerically pure isosorbide-2 and 5-monoesters as well as their conversion into isosorbide-2- and 5-nitrate
JPH05331157A (en) Ascorbic acid ester
JPH06740B2 (en) Process for producing optically active carboxylic acid amide
AU670088B2 (en) Enzymatic process to separate racemic mixtures of delta valerolactones
EP0239122B1 (en) Process for the enzymatic resolution of racemic 2-amino-1-alkanols
JPH06256278A (en) Optically active alpha-carbamoylalkanoic acid derivative and its production
JP3098332B2 (en) Enzymatic preparation of isomeric pure isosorbide-2- and -5-monoesters and their conversion to isosorbide-2- and -5-nitrate
JP2002171994A (en) Method for producing optically active tetrahydrofuran-2-carboxylic acid or its antipode ester
JP3072150B2 (en) Method for producing optically active [3] (1,1 ') ferrocenophanes
JP2655893B2 (en) Method for synthesizing optically active β-halolactic acid or glycidyl acid
JP3090286B2 (en) Method for producing carboxyalkyl acrylate and method for producing methoxycarbonylalkyl acrylate used in this method
JPH08332095A (en) Production of indenol
EP0472336A1 (en) Process for preparing optically active 3-hydroxybutane derivatives
JPS62205797A (en) Production of optically active compound
JPH0191789A (en) Production of optically active beta-substituted glutaric acid monoester
JP2639651B2 (en) Process for producing optically active carboxylic acid and its enantiomer ester
JP3046383B2 (en) Method for producing optically active indolehydroxy acids
JPH08119958A (en) Production of optically active chroman compound
JPS60130539A (en) Preparation of optically active styrene halohydrin
JPH10210997A (en) Production of optically active 3-quinacridinol
JP2899404B2 (en) Process for producing (R) -2-hydroxy-4-phenylbutyric acid
JPH0573396B2 (en)
JP3438389B2 (en) Method for selective esterification of phenol derivative having alcoholic hydroxyl group using lipase
JPH0475589A (en) Production of optically active norbornene derivative